Patent directory · USPTO A61K / A61P
Patents matching “THE REGENTS OF THE UNIVERSITY OF MICHIGAN”
774 pharma patents match "THE REGENTS OF THE UNIVERSITY OF MICHIGAN" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 774 pharmaceutical patents matching "THE REGENTS OF THE UNIVERSITY OF MICHIGAN" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11633511
Production of immune-response-stimulating aerosols by non-thermal plasma treatment of airborne pathogens
granted -
US 11613528
Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use
granted -
US 11607387
Efficient aqueous encapsulation and controlled release of bioactive agents
granted -
US 11607414
Small molecule inhibitors of EGFR and PI3K
granted -
US 11597749
Peptide compositions and methods of use
granted -
US 11597773
CD6 antibody for treatment of T-cell mediated diseases or disorders
granted -
US 11590234
Hyperbranched polymers and polyplexes and DNA or RNA delivery systems including the same
granted -
US 11571538
Gas delivery devices
granted -
US 11571389
Delivery devices and methods for making the same
granted -
US 11555041
Bridged bicyclic inhibitors of menin-MLL and methods of use
granted -
US 11547551
Engineered tendon graft for rotator cuff repair
granted -
US 11548899
Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors
granted -
US 11542248
Methods and compositions for inhibiting the interaction of menin with MLL proteins
granted -
US 11510996
Covalent polymer-antigen conjugated particles
granted -
US 11498928
Macrocyclic spiroethers as Mcl-1 inhibitors
granted -
US 11484591
Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin A analogues or metabolites, and estradiol metabolites
granted -
US 11478571
Synthetic hydrogel carriers for cellular structures, generation of organoids, and treatment of tissue injury
granted -
US 11466028
Fused 1,4-oxazepines as BET protein degraders
granted -
US 11452724
Methods for treating amyotrophic lateral sclerosis
granted -
US 11439609
Nitric oxide releasing PLGA microspheres for biomedical applications
granted -
US 11426368
Plasminogen activator inhibitor-1 (PAI-1) inhibitor and method of use
granted -
US 11413420
Nitric oxide delivery devices
granted -
US 11406720
Fibroblast growth factor receptor 2-specific peptide reagents and methods
granted -
US 11390848
Materials and methods for modifying the activity of T cells
granted